Pro Pharma Talks

1. What is the current situation?

     a. US – slow response, extremely poor national management, high uninsured rate, high out-of-pocket costs, and comparatively low medical system capacity 

     b. States in competition over purchasing PPE

2. What are other countries doing?

     a. International experience – management, global partnering

     b. Asian experience – using lessons learned from SARS outbreak

     c. European experience – emphasize testing

     d. Scandinavia

          i. Swedish model – remained open, highest global death rate, economy in worst crisis since WWII

          ii. Denmark/Norway – locked down

          iii. Finland has low level of immunity – fears of a second wave

     e. Taiwan Model

          i. Geopolitical fight with China

          ii. Serious history of respiratory diseases

          iii. Coordinate government’s response

          iv. Quick and efficient in deploying counter measures

3. What have we learned?

     a. Proactive management like every other pandemic is crucial

     b. Global partnerships are crucial

     c. Quick and efficient testing

     d. US complicated with high uninsured rate, high OOP costs, low medical system capacity

     e. US has greater disease burden

      f. US has smaller workforce and acute hospital bed capacity

     g. Considerable variation among states

_____

Make sure to subscribe to get the latest episode.

Contact Us:

Pharmacy Benefit News: http://www.propharmaconsultants.com/pbn.html

Email: [email protected]

Website: http://www.propharmaconsultants.com/

Facebook: https://www.facebook.com/propharmainc

Twitter: https://twitter.com/ProPharma/

Instagram: https://www.instagram.com/propharmainc/

LinkedIn: https://www.linkedin.com/company/pro-pharma-pharmaceutical-consultants-inc/

Podcast: https://anchor.fm/pro-pharma-talks

Podden och tillhörande omslagsbild på den här sidan tillhör Pro Pharma. Innehållet i podden är skapat av Pro Pharma och inte av, eller tillsammans med, Poddtoppen.